Introduction The use of phytochemical preparations is being promoted an supported worldwide. In order to investigate and confirm the usage of phytochemical preparations that are widely used in the traditional medicine, there is an urgent need to complete a chemical, phytochemical and clinical study for those medicinal preparations. Goal To investigate the effects of “Antitoxic preparation” on the test animal with previously developed acute hepatotoxic infection by LPS. Materials and Methods A pathology model of the acute liver infection was developed on a total of 50 Vister rats, weighing between 200 and 250 gr. The test animals were categorized info five five further groups, e.g. healthy, control, comparison and administered with 50 mg/kg and 100 mg/kg of “Antitoxic preparation”. The preparation for each group was individually and orally administeredfor a period of ten days. On day 11, 2nd, 3rd, 4th and 5th groups were administered 5 μg of LPS and 300 mg/kg of GaIN calculated in 2 ml of physiogial solution was injected in the abdomed of the test animal. After 8 hours, AST, ALT, cholesterol, triglycerides, level of MDA, cytokine levels such as TNF-α, IL-1β, IL-6, IL-10 contained in the blood plasma of test animals were analysed. Results A comparison between measurement of “Antitoxic preparation” group and control group has indicated that the AST was 24.9-30.8%, ALT 23.8-27.6%, Poenzyme activation was reduced by 29.1-32.6%, of cholesterol by 13.2-19.9%, of tryglyceride 23.4-30.5%, MDA in plasma 8.8-20.9%, MDA in urine 11.3- 22.9%, also reduction of TNF-α in plasma by 17.5-27.3% and IL-1β17.7-19.8% respectively. Also, it was determined that the cytokines activating the acute liver infection (TNF-α, IL-1β, IL-10) were impacted after administering the preparation and infection process was suppressed. Conclusions: 1. The pathological model for chronic toxic liver infection developed on the test animal indicated that “Antitoxic preparation” had a reducing effect on cholesterol, tryglycerides, inhibitory effect on activation of fat oxidation, choleretic, antioxidant, reducing effect on ALT, AST activation, reducing the destruction of liver cells and followed by hepatoprotective action. 2. “Antitoxic preparation” was effective in impacting the cytokines (TNF-α, IL-1β, IL-10) that activate the acute liver infection and also suppressing effect on infection process.

Background: Herpes zoster (shingles) is an acute inflammatory skin disease caused by the reactivation of the Varicel la-zoster virus. International studies show that the disease severely reduces patients’ quality of life, and chronic pain negatively affects daily activities. In clinical practice, bloodletting pricking therapy has been effectively used for herpes zoster, with positive effects including reducing disease symptoms, alleviating skin inflammation, and promoting skin regeneration. Due to the limited research on treating herpes zoster with combined bloodletting pricking therapy and acu puncture, this clinical study was conducted. Aim: To evaluate the effectiveness of combining bloodletting pricking therapy with acupuncture in patients diagnosed with herpes zoster. Materials and Methods: The study was conducted using a non-randomized clinical trial design based at the Internation al School of Mongolian Medicine of MNUMS and the Inner Mongolia International Mongolian Medicine Committee (IMIMC). The study included 70 patients diagnosed with herpes zoster (ICD 10-B02.9) who met the inclusion criteria. The treatment group received bloodletting pricking therapy combined with acupuncture. The control group received Acyclovir 800 mg 5 times daily for 7-10 days and Pregabalin 75 mg twice daily for 14 days. Treatment effectiveness was evaluated using the VAS linear scale for pain assessment, the SF-12 (Short Form-12 health survey) questionnaire for qual ity of life, and the Athens Insomnia Scale (AIS) to measure sleep quality and evaluate insomnia. The treatment outcome was assessed according to the Mongolian Traditional Medicine Diagnostic and Treatment Standards. Results: The average age of participants was 47.29±11.11 in the treatment group and 44.43±11.63 in the control group, with 34% male and 66% female participants. According to the VAS linear scale, the treatment group showed a statistically significant greater reduction in pain (P<0.001). The quality-of-life assessment using the SF-12 questionnaire showed that the Physical Component Summary (SF-12-PCS) in the treatment group increased from 32.71±7.38 before treatment to 52.99±2.02 after treatment (t=-17.18, p<0.001), while in the control group, it increased from 36.10±7.41 to 51.56±7.9 (SF-12-3.9) (p<0.001). According to the AIS questionnaire, the sleep quality in the treatment group was significantly better than in the control group (P<0.05). According to the Mongolian Traditional Medicine Diagnostic and Treatment Standards, the combined treatment of pricking therapy and acupuncture resulted in a 100% recovery rate. Conclusion 1. The combination of bloodletting pricking therapy and acupuncture in treating herpes zoster effectively reduces pain. 2. For patients diagnosed with herpes zoster, combining bloodletting pricking therapy with acupuncture effectively improves quality of life in terms of sleep quality as well as physical and mental functioning.